United States Traveler's Diarrhea Therapeutics Market Report 2017

January 2018 | 95 pages | ID: U505B5C94D7EN
QYResearch

Abstracts

In this report, the United States Traveler's Diarrhea Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Traveler's Diarrhea Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Traveler's Diarrhea Therapeutics market competition by top manufacturers/players, with Traveler's Diarrhea Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Salix Pharmaceuticals
• Chiesi Farmaceutici
• Cosmo Pharmaceuticals
• Nippon Shinyaku
• Prokarium Limited
• Scandinavian Biopharma
• Sigmoid Pharma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Anti-Motility Agents
• Bismuth Subsalicylate (Pepto-Bismol)
• Antibiotics

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Adult Traveler's Diarrhea
• Children Traveler's Diarrhea

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Traveler's Diarrhea Therapeutics Market Report 2017

1 TRAVELER'S DIARRHEA THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Traveler's Diarrhea Therapeutics
1.2 Classification of Traveler's Diarrhea Therapeutics by Product Category
  1.2.1 United States Traveler's Diarrhea Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Traveler's Diarrhea Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Anti-Motility Agents
  1.2.4 Bismuth Subsalicylate (Pepto-Bismol)
  1.2.5 Antibiotics
1.3 United States Traveler's Diarrhea Therapeutics Market by Application/End Users
  1.3.1 United States Traveler's Diarrhea Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Adult Traveler's Diarrhea
  1.3.3 Children Traveler's Diarrhea
1.4 United States Traveler's Diarrhea Therapeutics Market by Region
  1.4.1 United States Traveler's Diarrhea Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Traveler's Diarrhea Therapeutics Status and Prospect (2012-2022)
  1.4.3 Southwest Traveler's Diarrhea Therapeutics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Traveler's Diarrhea Therapeutics Status and Prospect (2012-2022)
  1.4.5 New England Traveler's Diarrhea Therapeutics Status and Prospect (2012-2022)
  1.4.6 The South Traveler's Diarrhea Therapeutics Status and Prospect (2012-2022)
  1.4.7 The Midwest Traveler's Diarrhea Therapeutics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Traveler's Diarrhea Therapeutics (2012-2022)
  1.5.1 United States Traveler's Diarrhea Therapeutics Sales and Growth Rate (2012-2022)
  1.5.2 United States Traveler's Diarrhea Therapeutics Revenue and Growth Rate (2012-2022)

2 UNITED STATES TRAVELER'S DIARRHEA THERAPEUTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Traveler's Diarrhea Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Traveler's Diarrhea Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Traveler's Diarrhea Therapeutics Average Price by Players/Suppliers (2012-2017)
2.4 United States Traveler's Diarrhea Therapeutics Market Competitive Situation and Trends
  2.4.1 United States Traveler's Diarrhea Therapeutics Market Concentration Rate
  2.4.2 United States Traveler's Diarrhea Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Traveler's Diarrhea Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES TRAVELER'S DIARRHEA THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Traveler's Diarrhea Therapeutics Sales and Market Share by Region (2012-2017)
3.2 United States Traveler's Diarrhea Therapeutics Revenue and Market Share by Region (2012-2017)
3.3 United States Traveler's Diarrhea Therapeutics Price by Region (2012-2017)

4 UNITED STATES TRAVELER'S DIARRHEA THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Traveler's Diarrhea Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Traveler's Diarrhea Therapeutics Price by Type (2012-2017)
4.4 United States Traveler's Diarrhea Therapeutics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES TRAVELER'S DIARRHEA THERAPEUTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Traveler's Diarrhea Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Traveler's Diarrhea Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES TRAVELER'S DIARRHEA THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Traveler's Diarrhea Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Salix Pharmaceuticals
  6.2.2 Traveler's Diarrhea Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Chiesi Farmaceutici
  6.3.2 Traveler's Diarrhea Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Chiesi Farmaceutici Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Cosmo Pharmaceuticals
  6.4.2 Traveler's Diarrhea Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Cosmo Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Nippon Shinyaku
  6.5.2 Traveler's Diarrhea Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Nippon Shinyaku Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Prokarium Limited
  6.6.2 Traveler's Diarrhea Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Prokarium Limited Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Scandinavian Biopharma
  6.7.2 Traveler's Diarrhea Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Scandinavian Biopharma Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Sigmoid Pharma
  6.8.2 Traveler's Diarrhea Therapeutics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sigmoid Pharma Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 TRAVELER'S DIARRHEA THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Traveler's Diarrhea Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Traveler's Diarrhea Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Traveler's Diarrhea Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Traveler's Diarrhea Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES TRAVELER'S DIARRHEA THERAPEUTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Traveler's Diarrhea Therapeutics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Traveler's Diarrhea Therapeutics Sales Volume Forecast by Type (2017-2022)
11.3 United States Traveler's Diarrhea Therapeutics Sales Volume Forecast by Application (2017-2022)
11.4 United States Traveler's Diarrhea Therapeutics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Traveler's Diarrhea Therapeutics
Figure United States Traveler's Diarrhea Therapeutics Market Size (K Units) by Type (2012-2022)
Figure United States Traveler's Diarrhea Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Anti-Motility Agents Product Picture
Figure Bismuth Subsalicylate (Pepto-Bismol) Product Picture
Figure Antibiotics Product Picture
Figure United States Traveler's Diarrhea Therapeutics Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Traveler's Diarrhea Therapeutics by Application in 2016
Figure Adult Traveler's Diarrhea Examples
Table Key Downstream Customer in Adult Traveler's Diarrhea
Figure Children Traveler's Diarrhea Examples
Table Key Downstream Customer in Children Traveler's Diarrhea
Figure United States Traveler's Diarrhea Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure The West Traveler's Diarrhea Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Traveler's Diarrhea Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Traveler's Diarrhea Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Traveler's Diarrhea Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Traveler's Diarrhea Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Traveler's Diarrhea Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Traveler's Diarrhea Therapeutics Sales (K Units) and Growth Rate (2012-2022)
Figure United States Traveler's Diarrhea Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Traveler's Diarrhea Therapeutics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Traveler's Diarrhea Therapeutics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Traveler's Diarrhea Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Traveler's Diarrhea Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Traveler's Diarrhea Therapeutics Sales Share by Players/Suppliers
Figure United States Traveler's Diarrhea Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Traveler's Diarrhea Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Traveler's Diarrhea Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Traveler's Diarrhea Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Traveler's Diarrhea Therapeutics Revenue Share by Players/Suppliers
Table United States Market Traveler's Diarrhea Therapeutics Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Traveler's Diarrhea Therapeutics Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Traveler's Diarrhea Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Traveler's Diarrhea Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Traveler's Diarrhea Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Traveler's Diarrhea Therapeutics Product Category
Table United States Traveler's Diarrhea Therapeutics Sales (K Units) by Region (2012-2017)
Table United States Traveler's Diarrhea Therapeutics Sales Share by Region (2012-2017)
Figure United States Traveler's Diarrhea Therapeutics Sales Share by Region (2012-2017)
Figure United States Traveler's Diarrhea Therapeutics Sales Market Share by Region in 2016
Table United States Traveler's Diarrhea Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Traveler's Diarrhea Therapeutics Revenue Share by Region (2012-2017)
Figure United States Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2012-2017)
Figure United States Traveler's Diarrhea Therapeutics Revenue Market Share by Region in 2016
Table United States Traveler's Diarrhea Therapeutics Price (USD/Unit) by Region (2012-2017)
Table United States Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2012-2017)
Table United States Traveler's Diarrhea Therapeutics Sales Share by Type (2012-2017)
Figure United States Traveler's Diarrhea Therapeutics Sales Share by Type (2012-2017)
Figure United States Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2016
Table United States Traveler's Diarrhea Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Traveler's Diarrhea Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Traveler's Diarrhea Therapeutics by Type (2012-2017)
Figure Revenue Market Share of Traveler's Diarrhea Therapeutics by Type in 2016
Table United States Traveler's Diarrhea Therapeutics Price (USD/Unit) by Types (2012-2017)
Figure United States Traveler's Diarrhea Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2012-2017)
Table United States Traveler's Diarrhea Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Traveler's Diarrhea Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2016
Table United States Traveler's Diarrhea Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Traveler's Diarrhea Therapeutics Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Traveler's Diarrhea Therapeutics Sales Growth Rate (2012-2017)
Figure GSK Traveler's Diarrhea Therapeutics Sales Market Share in United States (2012-2017)
Figure GSK Traveler's Diarrhea Therapeutics Revenue Market Share in United States (2012-2017)
Table Salix Pharmaceuticals Basic Information List
Table Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales Growth Rate (2012-2017)
Figure Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales Market Share in United States (2012-2017)
Figure Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Revenue Market Share in United States (2012-2017)
Table Chiesi Farmaceutici Basic Information List
Table Chiesi Farmaceutici Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Chiesi Farmaceutici Traveler's Diarrhea Therapeutics Sales Growth Rate (2012-2017)
Figure Chiesi Farmaceutici Traveler's Diarrhea Therapeutics Sales Market Share in United States (2012-2017)
Figure Chiesi Farmaceutici Traveler's Diarrhea Therapeutics Revenue Market Share in United States (2012-2017)
Table Cosmo Pharmaceuticals Basic Information List
Table Cosmo Pharmaceuticals Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cosmo Pharmaceuticals Traveler's Diarrhea Therapeutics Sales Growth Rate (2012-2017)
Figure Cosmo Pharmaceuticals Traveler's Diarrhea Therapeutics Sales Market Share in United States (2012-2017)
Figure Cosmo Pharmaceuticals Traveler's Diarrhea Therapeutics Revenue Market Share in United States (2012-2017)
Table Nippon Shinyaku Basic Information List
Table Nippon Shinyaku Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Nippon Shinyaku Traveler's Diarrhea Therapeutics Sales Growth Rate (2012-2017)
Figure Nippon Shinyaku Traveler's Diarrhea Therapeutics Sales Market Share in United States (2012-2017)
Figure Nippon Shinyaku Traveler's Diarrhea Therapeutics Revenue Market Share in United States (2012-2017)
Table Prokarium Limited Basic Information List
Table Prokarium Limited Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Prokarium Limited Traveler's Diarrhea Therapeutics Sales Growth Rate (2012-2017)
Figure Prokarium Limited Traveler's Diarrhea Therapeutics Sales Market Share in United States (2012-2017)
Figure Prokarium Limited Traveler's Diarrhea Therapeutics Revenue Market Share in United States (2012-2017)
Table Scandinavian Biopharma Basic Information List
Table Scandinavian Biopharma Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Scandinavian Biopharma Traveler's Diarrhea Therapeutics Sales Growth Rate (2012-2017)
Figure Scandinavian Biopharma Traveler's Diarrhea Therapeutics Sales Market Share in United States (2012-2017)
Figure Scandinavian Biopharma Traveler's Diarrhea Therapeutics Revenue Market Share in United States (2012-2017)
Table Sigmoid Pharma Basic Information List
Table Sigmoid Pharma Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sigmoid Pharma Traveler's Diarrhea Therapeutics Sales Growth Rate (2012-2017)
Figure Sigmoid Pharma Traveler's Diarrhea Therapeutics Sales Market Share in United States (2012-2017)
Figure Sigmoid Pharma Traveler's Diarrhea Therapeutics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Traveler's Diarrhea Therapeutics
Figure Manufacturing Process Analysis of Traveler's Diarrhea Therapeutics
Figure Traveler's Diarrhea Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Traveler's Diarrhea Therapeutics Major Players/Suppliers in 2016
Table Major Buyers of Traveler's Diarrhea Therapeutics
Table Distributors/Traders List
Figure United States Traveler's Diarrhea Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Traveler's Diarrhea Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Traveler's Diarrhea Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Traveler's Diarrhea Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Traveler's Diarrhea Therapeutics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Traveler's Diarrhea Therapeutics Sales Volume (K Units) Forecast by Type in 2022
Table United States Traveler's Diarrhea Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Traveler's Diarrhea Therapeutics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Traveler's Diarrhea Therapeutics Sales Volume (K Units) Forecast by Application in 2022
Table United States Traveler's Diarrhea Therapeutics Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Traveler's Diarrhea Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Traveler's Diarrhea Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Traveler's Diarrhea Therapeutics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources